Short-term observation of direct oral anticoagulant use in an atrial fibrillation patient with high bleeding risk and kidney transplant:a case report

作     者：Wei XIANG Ling-Yun KONG Jing BAI Jun-Jie XIE Fang LIU Wei XIANG;Ling-Yun KONG;Jing BAI;Jun-Jie XIE;Fang LIU

作者机构：Department of CardiologyBeijing Tsinghua Changgung HospitalSchool of Clinical MedicineTsinghua UniversityBeijingChina Department of Organ Transplant CenterBeijing Tsinghua Changgung HospitalSchool of Clinical MedicineTsinghua UniversityBeijingChina 

出 版 物：《Journal of Geriatric Cardiology》 (老年心脏病学杂志（英文版）)

年 卷 期：2021年第18卷第8期

页      面：692-696页

核心收录：

学科分类：1007[医学-药学(可授医学、理学学位)] 1006[医学-中西医结合] 100706[医学-药理学] 100602[医学-中西医结合临床] 10[医学] 

主　　题：fibrillation dialysis Kidney 

摘      要：Kidney transplant(KTx)is considered to be the best treatment for end-stage renal diseases compared with hemodialysis or peritoneal dialysis,because it significantly im-proves renal function,reduces cardiovascular events and mortality,enhances quality of life and prolongs life expectancy.[1,2]Atrial fibrillation(AF)is frequently coexistent with KTx,and a higher risk will occur in KTx recipients with AF compared with those aren’t with AF.[3]Patients with AF are at risk of stroke,systemic emboli and *** is recom-mended that high-risk AF patients should use oral anticoagulants for preventive *** oral anticoagulants(DOACs),including dabigatran,rivaroxaban,apixaban and edoxaban,are widely recommended for use in the general population compared to vitamin K antagonists(VKA).